Department of Urology, Faculty of Medicine, Zagazig University, 44519, Zagazig, Egypt.
Urolithiasis. 2017 Dec;45(6):585-589. doi: 10.1007/s00240-017-0966-1. Epub 2017 Feb 22.
To assess the safety and efficacy of minimally invasive percutaneous nephrolithotomy (mPCNL) as compared to standard PCNL (sPCNL) for management of 2-3-cm renal stones in the flank-free modified supine position. Between September 2010 and December 2013, 150 patients (168 renal units) with 2-3-cm renal stones were prospectively randomized into two treatment groups; Group A (75 patients/87 renal units) treated by mPCNL and Group B (75 patients/81 renal units) treated by sPCNL. In both groups, the patients were placed in the flank-free modified supine position. In mPCNL group, the tract was dilated up to 16.5 F whereas in sPCNL group the tract was dilated up to 30 F. Both groups were compared regarding several perioperative parameters. No significant difference was recorded among both groups regarding fluoroscopy time (4.3 ± 1.3 vs 4.8 ± 2.1 min, p = 0.06), operative time (83.2 ± 17.3 vs 78.6 ± 24.4 min, p = 0.16), hospital stay (4.3 vs 4.5 days, p = 0.76), VAS score (3.2 ± 0.6 vs 3.3 ± 0.8, p = 0.36) and need for analgesia. The mean drop in hemoglobin level and the incidence of bleeding that necessitated blood transfusion were significantly lower in the mPCNL group (0.6 ± 0.1 vs 1.9 ± 1.1 g/dl, p < 0.0001 and 1.2 vs 9.8%, p = 0.03, respectively). Although the stone-free rate was higher in the sPCNL group, but this was statistically insignificant (97.1 vs 95.4%, p = 0.86). Mini-PCNL is effective for managing renal calculi with comparable operative time and stone-free rate to standard PCNL with the merit of higher safety due to lower incidence of bleeding that necessitates blood transfusion.
在无侧卧位改良仰卧位下,评估微创经皮肾镜取石术(mPCNL)与标准经皮肾镜取石术(sPCNL)治疗 2-3cm 肾结石的安全性和有效性。2010 年 9 月至 2013 年 12 月,前瞻性随机将 150 例(168 个肾脏单位)2-3cm 肾结石患者分为两组:A 组(75 例/87 个肾脏单位)行 mPCNL 治疗,B 组(75 例/81 个肾脏单位)行 sPCNL 治疗。两组患者均采用无侧卧位改良仰卧位。mPCNL 组输尿管扩张至 16.5F,sPCNL 组输尿管扩张至 30F。比较两组围手术期各项参数。两组患者的透视时间(4.3±1.3 与 4.8±2.1min,p=0.06)、手术时间(83.2±17.3 与 78.6±24.4min,p=0.16)、住院时间(4.3 与 4.5d,p=0.76)、VAS 评分(3.2±0.6 与 3.3±0.8,p=0.36)和镇痛需求无显著差异。mPCNL 组血红蛋白水平下降程度和需要输血的出血发生率明显低于 sPCNL 组(0.6±0.1 与 1.9±1.1g/dl,p<0.0001 和 1.2%与 9.8%,p=0.03)。sPCNL 组的结石清除率更高,但无统计学意义(97.1%与 95.4%,p=0.86)。mPCNL 治疗肾结石有效,手术时间和结石清除率与 sPCNL 相似,但出血发生率较低,需要输血的比例较低,安全性更高。